Generate a tailored SOP for Dr. Steve Bloom. Improve your application with a focused, well-structured draft.
Steve Bloom is a leading researcher in the field of medicine, currently serving as Professor of Medicine at Imperial College London's Department of Metabolism, Digestion and Reproduction. His extensive career includes roles such as Head of Drug Development and Clinical Director at Pathology North West London. With over 1000 published papers in prestigious journals and an h-index of 157, Bloom has made significant contributions to the understanding of gut hormones and their impact on appetite regulation. His groundbreaking work in the 1980s established key insights into endocrine physiology and the role of neurotransmitters in appetite control. He co-founded Thiakis Ltd, a biotech company that commercialized findings related to the appetite-reducing hormone oxyntomodulin. Bloom has received multiple honors, including Fellowships in prominent scientific societies and two Honorary Doctorates from the University of Warwick and Brunel University. He actively participates in various advisory roles, including with AstraZeneca and the Royal College of Physicians, and remains an influential figure in medical research and clinical pathways.
Imperial College London • London, United Kingdom
Leading research in metabolism, digestion and reproduction, head of drug development, and clinical director.
Hammersmith Hospital • London, United Kingdom
Provided education and mentorship in medicine.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.